Ban on 'surprise' medical bills on track to take effect Jan. 1, 2022
The ban “surprise” medical bills, charges that hit insured patients at some of life’s most vulnerable moments, is on track to take effect on Jan. 1.
The ban “surprise” medical bills, charges that hit insured patients at some of life’s most vulnerable moments, is on track to take effect on Jan. 1.
Deadline coming on Washington long-term care: private or state plan?
Workers have just a few months to decide whether they want to buy a private plan and opt out of the state-managed program before a payroll deduction hits their paychecks starting in January.
Workers have just a few months to decide whether they want to buy a private plan and opt out of the state-managed program before a payroll deduction hits their paychecks starting in January.
Walmart insulin: Low-cost, private brand launched for diabetes patients
Walmart unveiled a low-cost version of analog insulin that it will sell in an effort to help Americans who struggle to pay for the diabetes drug.
Walmart unveiled a low-cost version of analog insulin that it will sell in an effort to help Americans who struggle to pay for the diabetes drug.
Cyberattack impacts 200,000 people connected to MultiCare Health Systems
A cyberattack has exposed the personal information of 200,000 people connected to Tacoma-based MultiCare Health Systems.
A cyberattack has exposed the personal information of 200,000 people connected to Tacoma-based MultiCare Health Systems.
New Washington law sets $100 cap on copayments for insulin
Many Washington residents with diabetes will have an easier time affording insulin this year, as a law imposes a $100 cap on patient copayments.
Many Washington residents with diabetes will have an easier time affording insulin this year, as a law imposes a $100 cap on patient copayments.
Trump administration issues regulations aimed at lowering prescription drug prices
The Trump administration has issued regulations that could lower prescription drug prices. It’s unclear whether the rules will withstand expected legal challenges or what the Biden administration will do with them.
The Trump administration has issued regulations that could lower prescription drug prices. It’s unclear whether the rules will withstand expected legal challenges or what the Biden administration will do with them.
Protective gear for medical workers begins to run low again
The new shortages come as the virus resumes its rapid spread and the number of hospitalized patients climbs.
The new shortages come as the virus resumes its rapid spread and the number of hospitalized patients climbs.